Cubist Systematic Strategies, LLC Cyclerion Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.96 - $1.78 $13,365 - $24,781	-13,922 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.56 - $2.99 $21,718 - $41,626	13,922 New	13,922 $24,000
Q3 2021 Nov 15, 2021	SELL	$2.73 - $4.13 $46,639 - $70,556	-17,084 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.18 - $4.29 $37,243 - $73,290	17,084 New	17,084 $67,000
Q1 2020 May 15, 2020	SELL	$2.46 - $5.84 $1,547 - $3,673	-629 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.8 - $13.43 $1,132 - $8,447	629 New	629 $2,000
Q3 2019 Nov 14, 2019	SELL	$8.12 - $14.54 $85,714 - $153,484	-10,556 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$9.6 - $22.85 $101,337 - $241,204	10,556 New	10,556 $121,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $170M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.